- The clinical benefits, ethics, and economics of stratified medicine and companion diagnosticsMark R Trusheim
MIT Sloan School of Management, 100 Main St E62 518, Cambridge, MA 01239 4307, USA Electronic address
Drug Discov Today 20:1439-50. 2015..It would be in the interests of payers to rediscover their heritage of direct investment in diagnostic development. ..
- Quantifying factors for the success of stratified medicineMark R Trusheim
Massachusetts Institute of Technology, Sloan School of Management and Center for Biomedical Innovation, 100 Main Street, Cambridge, Massachusetts 02139, USA
Nat Rev Drug Discov 10:817-33. 2011..It also illustrates the impact of the interplay of these factors on the economic feasibility of stratified medicine, which has important implications for public policy makers...
- Uncertain prognosis for high-quality diagnostics: clinical challenges, economic barriers and needed reformsMark R Trusheim
MIT Sloan School of Management, Cambridge, MA 02139 4307, USA
Pharmacogenomics 14:325-34. 2013....
- Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkersMark R Trusheim
MIT Center for Biomedical Innovation, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139 4307, USA
Nat Rev Drug Discov 6:287-93. 2007....